I2S: Growth in the 3rd quarter despite an annual decline

i2S saw its revenue rebound by 3.23% in the third quarter of 2025, indicating an improving market environment. Despite this, revenue for the first nine months remains down 7.89% compared to 2024, mainly due to the slowdown in DigiBook's performance. In contrast, the i2S Medcare and Twiga segments experienced notable growth, with i2S Medcare up 35% and 22% respectively.

Export revenue decreased by 18%, representing 67% of the group's total. i2S branded products, such as DigiBook and Orphie, play a key role, accounting for 83% of revenue. DigiBook sales were affected by investment delays, while i2S Orphie is on track to exceed 50% annual growth thanks to its international strategy.